Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | IGSF9 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of IGSF9 mRNA | CTD | PMID:22206623 | IGSF9 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol binds to ESR2 protein] which results in decreased expression of IGSF9 mRNA | CTD | PMID:20404318 | IGSF9 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of IGSF9 mRNA | CTD | PMID:36828454 | IGSF9 | Human | 17beta-estradiol | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of IGSF9 mRNA | CTD | PMID:32145629 and PMID:35192832 | IGSF9 | Human | 17beta-estradiol 3-benzoate | increases methylation | ISO | Igsf9 (Rattus norvegicus) | 6480464 | estradiol 3-benzoate results in increased methylation of IGSF9 promoter | CTD | PMID:27415467 | IGSF9 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | IGSF9 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | IGSF9 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Igsf9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of IGSF9 mRNA | CTD | PMID:21570461 | IGSF9 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IGSF9 mRNA | CTD | PMID:33387578 | IGSF9 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of IGSF9 mRNA | CTD | PMID:21179406 | IGSF9 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of IGSF9 mRNA | CTD | PMID:24780913 | IGSF9 | Human | acetamide | increases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of IGSF9 mRNA | CTD | PMID:31881176 | IGSF9 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | IGSF9 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of IGSF9 mRNA | CTD | PMID:32763439 | IGSF9 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of IGSF9 exon and Aflatoxin B1 results in decreased methylation of IGSF9 gene | CTD | PMID:27153756 and PMID:30157460 | IGSF9 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of IGSF9 intron | CTD | PMID:30157460 | IGSF9 | Human | allethrin | multiple interactions | ISO | Igsf9 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein | CTD | PMID:34896426 | IGSF9 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA | CTD | PMID:32699268 | IGSF9 | Human | alpha-Zearalanol | multiple interactions | ISO | Igsf9 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGSF9 mRNA | CTD | PMID:35163327 | IGSF9 | Human | arsenite(3-) | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of IGSF9 mRNA] | CTD | PMID:18929588 | IGSF9 | Human | arsenite(3-) | decreases expression | ISO | Igsf9 (Mus musculus) | 6480464 | arsenite results in decreased expression of IGSF9 mRNA | CTD | PMID:18929588 | IGSF9 | Human | benzo[a]pyrene | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of IGSF9 mRNA] | CTD | PMID:22228805 | IGSF9 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of IGSF9 mRNA | CTD | PMID:32234424 | IGSF9 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of IGSF9 3' UTR more ... | CTD | PMID:27901495 and PMID:30157460 | IGSF9 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of IGSF9 promoter | CTD | PMID:27901495 | IGSF9 | Human | benzo[a]pyrene | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of IGSF9 mRNA | CTD | PMID:22228805 and PMID:23735875 | IGSF9 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of IGSF9 exon and benzo(e)pyrene results in decreased methylation of IGSF9 promoter | CTD | PMID:30157460 | IGSF9 | Human | bisphenol A | affects expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of IGSF9 mRNA | CTD | PMID:25181051 | IGSF9 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of IGSF9 mRNA | CTD | PMID:36828454 | IGSF9 | Human | bisphenol A | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of IGSF9 mRNA | CTD | PMID:32145629 and PMID:35192832 | IGSF9 | Human | bisphenol A | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | bisphenol A results in increased expression of IGSF9 mRNA | CTD | PMID:29165653 and PMID:32156529 | IGSF9 | Human | bisphenol A | decreases methylation | ISO | Igsf9 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of IGSF9 promoter | CTD | PMID:27312807 | IGSF9 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of IGSF9 mRNA | CTD | PMID:26079696 | IGSF9 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of IGSF9 mRNA | CTD | PMID:21592394 | IGSF9 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of IGSF9 mRNA | CTD | PMID:26485663 | IGSF9 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA | CTD | PMID:21592394 | IGSF9 | Human | carbon nanotube | decreases expression | ISO | Igsf9 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | IGSF9 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to IGSF9 gene] | CTD | PMID:28238834 | IGSF9 | Human | choline | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA | CTD | PMID:20938992 | IGSF9 | Human | cyhalothrin | multiple interactions | ISO | Igsf9 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein | CTD | PMID:34896426 | IGSF9 | Human | cypermethrin | multiple interactions | ISO | Igsf9 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein | CTD | PMID:34896426 | IGSF9 | Human | dexamethasone | decreases expression | ISO | Igsf9 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of IGSF9 mRNA | CTD | PMID:27645313 | IGSF9 | Human | dexamethasone | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA] more ... | CTD | PMID:27645313 | IGSF9 | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of IGSF9 gene | CTD | PMID:22964155 | IGSF9 | Human | dibutyl phthalate | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of IGSF9 mRNA | CTD | PMID:21266533 | IGSF9 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of IGSF9 mRNA | CTD | PMID:30031762 | IGSF9 | Human | enniatin | increases expression | EXP | | 6480464 | enniatins results in increased expression of IGSF9 mRNA | CTD | PMID:36016515 | IGSF9 | Human | fenvalerate | multiple interactions | ISO | Igsf9 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein | CTD | PMID:34896426 | IGSF9 | Human | folic acid | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA | CTD | PMID:20938992 | IGSF9 | Human | gentamycin | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of IGSF9 mRNA | CTD | PMID:33387578 | IGSF9 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of IGSF9 mRNA | CTD | PMID:20044591 | IGSF9 | Human | inulin | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGSF9 mRNA | CTD | PMID:36331819 | IGSF9 | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of IGSF9 mRNA | CTD | PMID:35984750 | IGSF9 | Human | ketamine | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of IGSF9 mRNA | CTD | PMID:20080153 | IGSF9 | Human | L-methionine | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA | CTD | PMID:20938992 | IGSF9 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of IGSF9 mRNA | CTD | PMID:28903495 | IGSF9 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of IGSF9 exon and Methapyrilene results in decreased methylation of IGSF9 promoter | CTD | PMID:30157460 | IGSF9 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of IGSF9 gene | CTD | PMID:23968726 | IGSF9 | Human | N-Nitrosopyrrolidine | decreases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in decreased expression of IGSF9 mRNA | CTD | PMID:32234424 | IGSF9 | Human | O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of IGSF9 mRNA | CTD | PMID:32234424 | IGSF9 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | IGSF9 | Human | paracetamol | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of IGSF9 mRNA | CTD | PMID:33387578 | IGSF9 | Human | PCB138 | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | IGSF9 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGSF9 mRNA | CTD | PMID:36331819 | IGSF9 | Human | perfluorooctanoic acid | multiple interactions | ISO | Igsf9 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGSF9 mRNA | CTD | PMID:35163327 | IGSF9 | Human | piperonyl butoxide | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of IGSF9 gene | CTD | PMID:23968726 | IGSF9 | Human | pirinixic acid | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of IGSF9 mRNA | CTD | PMID:20813756 | IGSF9 | Human | pyrethrins | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Pyrethrins results in decreased expression of IGSF9 protein | CTD | PMID:34896426 | IGSF9 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of IGSF9 mRNA | CTD | PMID:23557933 | IGSF9 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of IGSF9 mRNA | CTD | PMID:29301061 | IGSF9 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of IGSF9 mRNA | CTD | PMID:31533062 | IGSF9 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of IGSF9 mRNA | CTD | PMID:21592394 | IGSF9 | Human | testosterone | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of IGSF9 mRNA | CTD | PMID:33848595 | IGSF9 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA | CTD | PMID:21592394 | IGSF9 | Human | tetrachloromethane | decreases expression | ISO | Igsf9 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of IGSF9 mRNA | CTD | PMID:31150632 | IGSF9 | Human | tributylstannane | increases expression | ISO | Igsf9 (Mus musculus) | 6480464 | tributyltin results in increased expression of IGSF9 mRNA | CTD | PMID:31939706 | IGSF9 | Human | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of IGSF9 mRNA | CTD | PMID:22378314 | IGSF9 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of IGSF9 gene | CTD | PMID:29154799 | IGSF9 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of IGSF9 mRNA | CTD | PMID:23179753 and PMID:28001369 | IGSF9 | Human | valproic acid | multiple interactions | ISO | Igsf9 (Mus musculus) | 6480464 | KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]] and Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA] | CTD | PMID:27645313 | IGSF9 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of IGSF9 mRNA | CTD | PMID:25979313 | IGSF9 | Human | zearalenone | decreases expression | EXP | | 6480464 | Zearalenone results in decreased expression of IGSF9 mRNA | CTD | PMID:36828454 | |